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Abstract
Delirium occurring in patients with dementia is referred to as delirium superimposed on dementia 
(DSD). People who are older with dementia and who are institutionalized are at increased risk of 
developing delirium when hospitalized. In addition, their prior cognitive impairment makes 
detecting their delirium a challenge. The Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition and the International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision are considered the standard reference for the diagnosis of delirium and 
include criteria of impairments in cognitive processes such as attention, additional cognitive 
disturbances, or altered level of arousal. The Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition and the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision does not provide guidance regarding specific tests for assessment 
of the cognitive process impaired in delirium. Importantly, the assessment or inclusion of 
preexisting cognitive impairment is also not addressed by these standards. The challenge of DSD 
gets more complex as types of dementia, particularly dementia with Lewy bodies, which has 
features of both delirium and dementia, are considered. The objective of this article is to critically 
review key elements for the diagnosis of DSD, including the challenge of neuropsychological 
assessment in patients with dementia and the influence of particular tests used to diagnose DSD. 
To address the challenges of DSD diagnosis, we present a framework for guiding the focus of 
future research efforts to develop a reliable reference standard to diagnose DSD. A key feature of a 
reliable reference standard will improve the ability to clinically diagnose DSD in facility-based 
patients and research studies.
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Delirium is an acute neuropsychiatric disorder characterized by a disturbance in attention 
and awareness, which develops over a short period of time, with additional disturbance in 
cognition that are not explained by a preexisting cognitive impairment. Delirium that occurs 
in patients with dementia is referred to as delirium superimposed on dementia (DSD).1 
People who are older with dementia and who are institutionalized are at increased risk of 
developing delirium when hospitalized. In addition, their prior cognitive impairment makes 
detecting their delirium a challenge. The prevalence of DSD in institutionalized patients 
ranges from 1.4% to 70% according to the diagnostic tools,2 whereas the prevalence in 
community and hospital populations ranges from 22% to 89%.1 It is associated with higher 
health care costs, worse functional outcomes, and higher mortality rates compared with 
patients with dementia alone.1,3–6 It was estimated that 35.6 million people lived with 
dementia worldwide in 2010, with the prevalence expected to nearly double every 20 years, 
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to 65 million in 2030 and 115 million in 2050.7 Therefore, DSD by inference will affect 
millions of people worldwide especially in nursing home facilities.
The diagnosis of delirium currently relies on the diagnostic criteria of the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the International 
Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 
(Table 1).8,9 These 2 standard references are similar in the definition of delirium, but it 
should be noted that no specific criteria are provided to clinicians or researchers in either 
system to assist with the diagnosis of DSD. The DSM-5 specifies that the cognitive deficits 
should not be better explained by a preexisting, established, or evolving neurocognitive 
disorder. In the ICD-10, preexisting cognitive deficits are not considered.
Thirty years ago Lipowski10 provided a reference work for the definition of the concept of 
delirium. During the following years several terms have been used to define delirium. There 
has been an attempt to reduce the heterogeneity of delirium terminology to avoid 
“confusion” in clinical work and especially in research studies. The challenge to achieve 
clarity is even greater when delirium is considered in patients with preexisting dementia. In 
this context several terms have been used: sundowning, acute dementia, rapidly progressive 
dementia, acute confusion, delirium in cognitively impaired patients, and DSD.11
Although dementia may have more consistent terminology, the breadth of cognitive 
impairments in dementia nonetheless makes the assessment of baseline (and incident 
changes) in cognitive function challenging. Although some advocates prefer standardized 
testing, the progressive nature of dementia limits the battery of tests available. In addition, 
the growing diversity of the world population and the increasing challenge of dementia 
worldwide necessitate the availability of assessments in languages other than English.
The lack of standardization in the assessment of DSD may have potential significant clinical 
and research implications. The DSM-5 and the ICD-10 do not provide clinicians with 
indications of specific tests for assessment of attention or additional cognitive disturbances 
in cognition or altered level of arousal. Importantly, the assessment or inclusion of 
preexisting cognitive impairment is also not addressed by either the DSM-5 or ICD-10. 
Meagher et al12 have recently attempted to provide a standardized approach to the use of the 
DSM-5 criteria for delirium to avoid “confusion” even with the use of the standard 
reference.12
As the DSM-5 and the ICD-10 are considered the standard reference for the diagnosis of 
delirium, then several practical limitations should be considered.
First, attention has multiple domains,13 and there is not a clear DSM-5 and ICD-10 guidance 
regardingwhich domain orattention test should be used in patients with dementia, dementia 
stage, or dementia subtypes.
Second, the clinician is currently not provided with clear and predetermined methodology 
for how to ascertain the time of onset of delirium, the change from baseline, and fluctuation 
over the course of the day.
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Third, there is no reference for how to determine the presence of a preexisting 
neurocognitive disorder or the level of arousal.
As a result, we formed a task force of European Delirium Association 
(www.europeandeliriumassociation.com), American Delirium Association 
(www.americandeliriumsociety.org), and Australasian Delirium Association 
(www.delirium.org.au) society members, collectively called iDelirium (www.idelirium.org), 
to (1) clarify the key elements for the diagnosis of DSD, (2) review evidence of DSD 
diagnosis, and (3) formulate a path for the future direction of research in DSD.
The Challenge of Neuropsychological Assessment of Delirium in Patient 
With Dementia
Attention Deficits
Inattention is considered a core feature of delirium (criterion A, DSM-5) and a valid 
assessment of attention is, therefore, central to the diagnosis.
Definition of attention
Attention is widely studied in neuropsychology, but there is not a single definition. A 
possible definition proposed by Cohen is the “ability to focus on a selected stimulus, 
sustaining that focus and shifting it at will.”14 Three major functions of attention are (1) 
orienting to sensory events, (2) detecting signals for focal processing, and (3) maintaining a 
vigilant or alert state.13,15 These are reflected to some extent in the DSM-5 criteria for 
delirium, which state that patients must demonstrate a reduced ability to direct, focus, 
sustain, and shift attention.8 However, elements of executive function fall under the umbrella 
name of inattention and include much higher level cognitive tasks that are likely to be 
impaired in dementia, such as shifting and divided attention (multitasking).
Attentional deficits in delirium and dementia
The extent to which different aspects of attention are affected in delirium is poorly 
understood. Marked impairments in focusing and sustaining attention (ie, the ability to 
maintain attention to stimuli over time) are considered the hallmark feature of delirium.16–18 
One of the key challenges of delirium diagnosis is that the severity of attentional deficits in 
delirium varies greatly between patients (and also sometimes within the same patient at 
different time points), ranging from subtle impairments in complex working memory tasks, 
to more pronounced deficits in orienting and focusing attention, and finally to a state of 
lowered level of arousal whereby patients are unable to respond to simple commands. 
DSM-5 does offer some guidance on this matter, as it states that an inability to engage in 
standardized testing or interview should be classified as severe inattention.19
Complex attentional impairments may be found in the early stages of Alzheimer disease 
(AD) dementia (without delirium), but overall the ability to focus and sustain attention is 
relatively preserved in the earlier stages of AD.20 Conversely, it has been shown that 
sustained, divided, and selected attention are compromised in the moderate to severe stages 
of dementia.21 The type of dementia is also a factor. For example, patients with Lewy body 
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dementia have considerably greater impairment of attention compared with patients with 
another type of dementia.22 Given the centrality of inattention to the definition of delirium, 
much more needs to be learned about the nature of attentional deficits in both dementia and 
delirium if criteria for the diagnosis of DSD are to be optimized.
Tests to evaluate inattention
There is no consensus on how attention should be assessed,23 and most existing tests 
differentiate the inattention found in delirium from that in dementia.24,25 This uncertainty 
impedes progress in clinical practice and research. Several neuropsychological tests are 
currently used to assess inattention in delirium including digit span, spatial span, months of 
the year and days of the week backwards, and serial sevens.18 A recent review of studies on 
attention assessment in delirium concluded that cancellation tests (ie, test to determine an 
individual’s ability to detect targets among a range of similar stimuli, usually digits or 
letters), span tests, and computerized tests of sustained attention appear to offer utility in 
discriminating delirium from dementia.18 Months of the year backwards, one of the most 
widely used attention test in clinical practice, appears to have high sensitivity to delirium in 
older hospitalized patients.26–28
In general, caution is warranted when generalizing these findings. Further, tests are often 
labeled as measuring inattention when they also depend on other cognitive components, 
which themselves are more likely to be affected in dementia. There is an overlap of 
attention, working memory, and executive control. For instance, digit span is used as a 
measure of inattention, but it is also used to measure executive function and working 
memory. Cognitively simple tests that rely on focusing and sustaining attention rather than 
manipulating information or testing memory may be especially useful in discriminating 
delirium from dementia. For instance, in preschool children, attention deficits have been 
evaluated moving slowly a simple picture in front of the patient’s face while verbally 
prompting them to look at the picture and evaluating their ability to look at the pictures 
when their eyes are open.29
Arousal, Awareness, and Motor Fluctuations
Different cognitive domains are affected in dementia. For example, although the ability to 
learn is reduced, an individual may still have little difficulty with perceptual motor 
functioning, and perhaps be slightly less impaired in selective attention in comparison with 
the ability to divide attention. Clearly, the ability to engage cognition depends on the degree 
of arousal (Figure 1). The term “arousal” can be defined as the level of sensory stimulation 
that is required to keep the patient attending to the examiner’s question or following a 
command.30
The key role of arousal in delirium was first recognized over 3 decades ago and is now well 
established. In 1980, the Diagnostic and Statistical Manual of Mental Disorders (DSM) III 
version indicated that impaired consciousness was a core symptom of delirium, and this 
criterion was confirmed in subsequent years by almost all the classification systems. In what 
seems to be a reversal in this guidance, the current DSM-5 places greater emphasis on 
awareness, attention, and other cognitive disorders while de-emphasizing consciousness.8 
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Indeed, criterion D of DSM-5 states that inattention and changes in cognition must not occur 
in the context of a severely reduced level of arousal such as coma. Far from being a 
downgrading of the role of arousal in delirium, these criteria implicitly admit that arousal 
disorders are an integral aspect of this condition.19 In fact, both attention and arousal are 
hierarchically related; it is possible to have full arousal, but profound inattention (eg, 
hypervigilance), but not the other way around,31 (ie, when disorders of arousal exist 
inattention is always present).19 In other words, the DSM-5 criteria identify a threshold (ie, 
coma) under which a patient cannot be regarded as delirious, but does not reject the role of 
arousal in delirium phenomenology.19
Leonard et al32 have reported that delirium may be distinguished from dementia by virtue of 
the disproportionate impairment of vigilance and attention. Importantly, arousal is generally 
preserved in advanced chronic cognitive disorders,16 while attention and cognition (ie, 
orientation, memory, language, and executive functions) are usually already impaired in the 
moderate stages of dementia26,33 and especially when dementia is severe.34 A 
pathophysiological explanation relies on evidence that performance on attentional and 
general cognitive tasks, when administered, is contingent on brain activity in distributed 
cortical areas,35 which are generally damaged in the advanced stages of dementia, while 
arousal assessment tests structures in the brainstem.36 Because the hierarchical pattern of 
neuro-degeneration in AD begins in the entorhinal/perirhinal cortex, then progresses in the 
hippocampus and in association cortex, and finally in the primary neocortex (NIA-RI 
Consensus 1997), it could be hypothesized that attentional and other cognitive tasks cannot 
be assessed when the damage in the brain is advanced. On the contrary, arousal assessment 
may be feasible when dementia is severe. To indirectly support this observation, it is not 
surprising that studies to discriminate neuropsychological profiles of delirious and demented 
patients have generally recruited individuals with mild or, at most, moderate stages of 
dementia.
Tieges et al37 developed a new approach with the Observational Scale of Level of Arousal 
(OSLA)37 to detect delirium by observing eye opening, eye contact, as well as patient 
posture and movement. Delirium is not an isolated mental disorder but affects motor 
function as well.38,39 The evaluation of posture and movement might indeed be of interest in 
the context of patients with dementia. A study comparing 4 groups of 15 patients (with 
delirium alone, with dementia alone, with DSD, and with neither delirium nor dementia) 
found that when delirium develops, a worsening of motor performance also occurs.39 In 
patients with preexisting dementia, the resolution of delirium did not result in a significant 
improvement of specific cognitive functions, providing indirect evidence that when dementia 
is advanced, the cognitive testing does not provide good information to support the diagnosis 
of delirium. In this case, an assessment of motor abilities may assume a more specific 
diagnostic utility.39
In this regard, the Richmond Agitation and Sedation Scale (RASS),40,41 a scale originally 
evaluated to monitor the level of consciousness in critically ill patients, might provide 
important information on motor fluctuations given its potential to identify motor subtypes of 
delirium. Negative scores on the RASS may indicate hypoactive behavior in delirium and 
positive scores indicative of a hyperactive behavior. The scale has been recently modified 
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and adapted for use in general wards (ie, the modified RASS or m-RASS).42 Both the RASS 
and the m-RASS are ultra-brief assessments of the level of consciousness, and recent studies 
have suggested that they have high specificity for delirium in geriatrics wards, emergency 
departments,37,42,43 and specifically in patients with dementia.44
It could, therefore, be hypothesized that when dementia is severe or very severe, and 
attention cannot be tested using tools that require a certain level of cognition, arousal, and 
basic motor performance may be routinely assessed to detect delirium. For example, the 
observation of an unexpected drowsiness or failure to sit up from the bed in patients who 
were previously alert and able to move could suggest delirium in patients with dementia. 
Mobility performances in patients with dementia may similarly be used to detect incipient 
delirium.
Dementia With Lewy Bodies and the Influence on Tests Used to Diagnose 
Delirium
The clinical phenotypes of dementias show some overlap with delirium. For example, 
fluctuating cognition is seen in AD and vascular dementia; however, the prevalence and 
severity of fluctuation is greatest in dementia with Lewy bodies (DLB) (Table 2).45 
Similarly, complex visual hallucinations and delusions frequently occur in DLB, Parkinson 
disease dementia, and delirium but are seen in only 4%–8% of patients with AD.46 As a 
result, it is harder to differentiate DLB from delirium in comparison with other dementias 
according to the key features as identified by Meagher et al47 (attentional deficits, sleep-
wake cycle disturbance, impaired higher level thinking disturbances). DLB is viewed by 
many as the most challenging dementia subtype in which to diagnose DSD.48
There is a pressing need to develop methods to distinguish delirium and DLB. Lewy body 
disease is the second most common form of dementia in older people with a prevalence of 
15%–20% of all dementias at autopsy.49 The prevalence of older adults with 2 or more DLB 
symptoms in nursing homes ranges from 16% to 20%.50 Furthermore, patients with DLB 
also appear to be more acutely sensitive to minor insults (even subclinical events) and, thus, 
more delirium “prone.” Consequently, and unsurprisingly, delirium is more commonly 
diagnosed in DLB than AD51 with 32% of outpatients with DLB experiencing delirium as 
opposed to 15% of outpatients with AD.52
Differentiating DSD from DLB or delirium alone is vital to guide initial management and 
safe prescribing. Incorrectly diagnosing an acute change as a deterioration in patients with 
existing DLB rather than delirium can result in the under-investigation of common causes of 
delirium, such as infections, medications, and pain and inadequate management of this 
potentially life threatening medical emergency. Conversely, the lack of recognition of 
undiagnosed DLB in someone with delirium may result in patients being treated with 
antipsychotic medications. Such agents can significantly worsen features of their DLB, such 
as parkinsonism and cognitive impairment/arousal, and significantly increase the risk of 
mortality.53 Furthermore, a failure to diagnosis DLB may mean that patients miss out on 
appropriate treatments, such as cholinesterase inhibitors, which have been shown to improve 
hallucinations, delusions, and cognition in patients with DLB.54 Given findings that suggest 
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cholinesterase inhibitors might worsen delirium outcomes,55 it is imperative to make an 
accurate diagnosis of DLB in these settings.
Because of these overlapping clinical phenotypes, collateral history is essential to the 
identification of delirium in patients with DLB. Clinicians need to be vigilant to an acute, 
distinct change compared with baseline, including increased fluctuations in someone who 
previously had predominantly parkinsonism and hallucinations. In those with delirium, a 
previous history of symptoms including autonomic dysfunction (ie, recurrent dizziness, 
blackouts, constipation, urinary urgency, etc), rapid eye movement (REM) sleep behavior 
disorder, anosmia, visuoperceptual disturbances, as well as psychosis and episodes of 
delirium, along with clinical examination findings of parkinsonism (eg, bradykinesia, 
hypomimia, tremor, rigidity, change in posture, recurrent falls, or altered gait), may all 
suggest an undiagnosed DLB. The best methods to elicit these collateral histories may 
provide a focus for future diagnostic work to assist with the diagnosis of delirium in patients 
with DLB.
Research into how to recognize delirium in people with DLB may also focus on developing 
methods to test features that are most likely to differ, including cognitive domains such as 
orientation, vigilance, and psychomotor disturbances.49 Currently, when there is a suspicion 
of DLB, diagnostic biomarkers, such as a DaT SCAN may be helpful,56 although from a 
practical point of view, these usually need to be performed after the delirium episode ends. 
The role of objective biomarkers measurements, such as electroencephalography (EEG) to 
distinguish delirium and DLB, is appealing, however, EEG patterns in delirium overlap with 
those seen in DLB, making the differentiation more difficult. More advanced methods of 
EEG processing/quantification may illuminate other specific nuances between delirium and 
DLB and could provide a focus for future research.
Framework for Improving the Diagnosis of DSD
There are many gaps in our knowledge about how to diagnose DSD with a high degree of 
accuracy. The current state of the science does not provide guidance on which clinical tests 
and biomarkers should be specifically tested in patient with DSD. Additional challenges are 
related to the possible difference in DSD presentation in patients with different types of 
dementia (Figure 2).
Here we provide a consensus from the iDelirium group on research that is needed to clarify 
important key points in the diagnosis of DSD (Table 3).
Improving Attention Testing
(1) Define which types of attention should be tested; (2) Define what type of attention 
should be tested according to the type of dementia and severity of dementia; (3) Define what 
attention tests should be used according to the type of dementia and severity of dementia.
Impact of Arousal/Awareness/Motor Fluctuations
(1) Further define the implications for using the RASS, m-RASS, or OSLA to diagnosis 
DSD and the possible implications on outcomes; (2) Define the role of the use of objective 
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evaluation of the level of motor fluctuation (eg, actigraphy monitoring) for the diagnosis of 
DSD; (3) Define the importance and the possible use of clinical evaluation of motor 
fluctuation using bed-side tests (eg, Tinetti scale, hierarchical assessment of balance and 
mobility).
Clinical Evaluation of DSD
Define a specific protocol to collect information from family members, review of medical 
records, to determine basic and instrumental activities of daily living, and to determine prior 
cognitive function using a standardized collateral informant questionnaire, such as the SF-
IQCODE (Short Form of the Informant Questionnaire on Cognitive Decline in the Elderly) 
or the AD8.
Clinical Examination
Define which component of the neurologic examination might be useful or indicative in the 
diagnosis of DSD (eg, tendon reflexes, plantar reflexes, UPM/extrapyramidal, archaic 
reflexes, myoclonia; eye examination including pupil size, light reflex, oculocephalic 
response; cough reflex, grimace).
Laboratory Testing
(1) Define a core set of laboratory evaluation for the clinical diagnosis of DSD; (2) Define a 
core set of laboratory evaluation for the research diagnosis of DSD.
Neuroimaging
(1) Clarify the role of neuroimaging in the clinical diagnosis of DSD; (2) Provide indications 
for the use of neuroimaging techniques for a research standard of diagnosis of DSD (eg, 
brain magnetic resonance imaging, DaT SCAN).
Summary
DSD is a clinical syndrome that can result in very poor outcomes. Accurate identification 
has so far been elusive. In this report, we have presented descriptions of its presentation and 
associated clinical findings, and the insufficiency of current diagnostic assessment tools. We 
hope that our framework will be helpful for the improved delineation of this highly 
problematic geriatric clinical syndrome.
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Fig. 1. 
Cognitive domains and arousal. Different cognitive domains are affected in dementia, but the 
ability to engage cognition depends on the degree of arousal. In the radar plot to the left of 
the figure, this particular individual has almost normal arousal, perhaps being somewhat 
hyperalert (dashed circle signals “normal” arousal). With the onset of delirium, most 
cognitive domains deteriorate as arousal decreases (degree of arousal = dotted red circle) as 
could be the case given hypoactive delirium (radar plot to the right). In this constellation of 
an individual having shown cognitive impairment, including attention, prior to delirium, it is 
especially challenging to adequately test for specific change in any one of multiple 
attentional domains (marked 1). It is, moreover, as difficult to determine the time of onset 
given that change is not from a nonimpaired state (marked 2; the solid black line on the 
timeline signals the fluctuating degree of cognitive impairment, in close relationship to the 
severity of delirium symptoms), not knowing how severe the baseline impairment (dotted 
red line on the timeline) actually was (marked 3).
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Fig. 2. 
The challenge of delirium across different types of dementia and possible overlap with 
behavioral and psychological symptoms of dementia (BPSD). AD, Alzheimer dementia; 
DLB, dementia with lewy bodies; VaD, vascular dementia; PD, Parkinson dementia.
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Table 1
DSM-5 and ICD-10 Diagnosis of Delirium
DSM-5 ICD-10
Attention Disturbance in ability to direct, focus, 
sustain, or shift and
Reduced ability to focus, sustain, or shift attention.
Awareness Disturbance in awareness environmental 
orientation
Clouding of consciousness, that is, reduced clarity of awareness of the 
environment
Timing/fluctuation Develops quickly (hours to days) and 
represents a change from baseline and 
fluctuates over a day
Rapid onset and fluctuations of the symptoms over the course of the 
day.
Memory deficit An additional disturbance in cognition 
(eg, memory deficit, disorientation, 
language, visuospatial ability, or 
perception).
Disturbance of cognition, manifest by both:
1 impairment of immediate recall and recent memory, 
with relatively intact remote memory;
2 disorientation in time, place, or person.
Psychomotor deficit None At least 1 of the following psychomotor disturbances:
1 rapid unpredictable shifts from hypoactivity to 
hyperactivity;
2 increased reaction time;
3 increased or decreased flow of speech;
4 enhanced startle reaction.
Sleep disturbance None Disturbance of sleep or the sleep/wake cycle, manifest by at least 1 of 
the following:
1 insomnia, which in severe cases may involve total sleep 
loss, with or without daytime drowsiness, or reversal of 
the sleep/wake cycle;
2 nocturnal worsening of symptoms;
3 disturbing dreams and nightmares that may continue as 
hallucinations or illusions after awakening.
Corroborating Data There is evidence from the history, 
physical examination, or laboratory 
findings that the disturbance is a direct 
physiological consequence of another 
medical condition, substance 
intoxication or withdrawal, or exposure 
to a toxin, or is due to multiple 
etiologies.
Objective evidence from history, physical and neurologic examination, 
or laboratory tests of an underlying cerebral or systemic disease (other 
than psychoactive substance-related) that can be presumed to be 
responsible for the clinical manifestations.
Other cognitive disorders Not better explained by a preexisting, 
established or evolving neurocognitive 
disorder and do not occur in the context 
of a severely reduced level of arousal, 
such as coma.
None
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Table 2
Delirium and DLB: Overlap and Differences
Delirium DLB
Onset: Acute onset Onset: Gradual and progressive onset
Cognitive impairment: fluctuation in attention, executive functioning, 
memory, visuospatial deficits
Cognitive impairment: fluctuation in attention, executive functioning, 
vigilance, memory, visuospatial deficits
Perceptual disturbances: visual and auditory hallucinations, delusions Perceptual disturbances: recurrent structured visual hallucinations, 
delusions
Sleep wake-cycle: disturbance in sleep wake-cycle Sleep wake-cycle: REM sleep behavior disorder
Motor signs: hyperactive or hypoactive motor signs Motor signs: parkinsonism motor signs
Neuroleptic sensitivity: non present Neuroleptic sensitivity: severe neuroleptic sensitivity
DLB, dementia with lewy bodies; REM, rapid eye movement.
J Am Med Dir Assoc. Author manuscript; available in PMC 2017 March 30.
Morandi et al. Page 17
Table 3
Framework for Improving the Diagnosis of DSD
Improving attention testing 1 Define what type of attention should be tested
2 Define what type of attention should be tested according to the type of dementia and severity 
of dementia
3 Define what attention test should be used according to the type of dementia and severity of 
dementia
Impact of arousal/awareness/
motor fluctuations
1 Further define the implication on the use of the RASS, m-RASS, OSLA on the diagnosis of 
DSD and their possible implications on outcomes
2 Define the role of the use of objective evaluation of the level of motor fluctuation (eg, 
actigraphy monitoring) on the diagnosis of DSD
3 Define the importance and the possible use of clinical evaluation of motor fluctuation using 
bed-side tests (eg, Tinetti scale, hierarchical assessment of balance and mobility)
Clinical evaluation of DSD Define how clinicians should test DSD using clinical information collected from family members, medical 
record review, and evaluation of basic and instrumental activities of daily living
Clinical exam Define which component of the neurologic examination might be useful or indicative in the diagnosis of 
DSD
Laboratory testing 1 Define a core set of laboratory evaluation for the clinical diagnosis of DSD
2 Define a core set of laboratory evaluation for the research diagnosis of DSD
Neuroimaging 1 Clarify the role of neuroimaging in the clinical diagnosis of DSD
2 Provide indications on which neuroimaging techniques could be of use in the research 
diagnosis of DSD (eg, brain magnetic resonance imaging, DaT SCAN)
